scispace - formally typeset
F

Felix Randow

Researcher at Laboratory of Molecular Biology

Publications -  64
Citations -  20139

Felix Randow is an academic researcher from Laboratory of Molecular Biology. The author has contributed to research in topics: Autophagy & Ubiquitin. The author has an hindex of 41, co-authored 62 publications receiving 16683 citations. Previous affiliations of Felix Randow include Medical Research Council & Harvard University.

Papers
More filters
Journal ArticleDOI

Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

Daniel J. Klionsky, +2522 more
- 21 Jan 2016 - 
TL;DR: In this paper, the authors present a set of guidelines for the selection and interpretation of methods for use by investigators who aim to examine macro-autophagy and related processes, as well as for reviewers who need to provide realistic and reasonable critiques of papers that are focused on these processes.
Journal ArticleDOI

Guidelines for the use and interpretation of assays for monitoring autophagy

Daniel J. Klionsky, +1287 more
- 01 Apr 2012 - 
TL;DR: These guidelines are presented for the selection and interpretation of methods for use by investigators who aim to examine macroautophagy and related processes, as well as for reviewers who need to provide realistic and reasonable critiques of papers that are focused on these processes.
Journal ArticleDOI

Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)

Daniel J. Klionsky, +2983 more
- 08 Feb 2021 - 
TL;DR: In this article, the authors present a set of guidelines for investigators to select and interpret methods to examine autophagy and related processes, and for reviewers to provide realistic and reasonable critiques of reports that are focused on these processes.
Journal ArticleDOI

Monocyte deactivation in septic patients: restoration by IFN-gamma treatment.

TL;DR: Recovery of monocyte function resulted in clearance of sepsis in eight of nine patients and suggests that IFN-γ treatment in carefully selected septic patients is a novel therapeutic strategy worth pursuing.
Journal ArticleDOI

Galectin 8 targets damaged vesicles for autophagy to defend cells against bacterial invasion

TL;DR: It is shown in human cells that galectin 8 (also known as LGALS8), a cytosolic lectin, is a danger receptor that restricts Salmonella proliferation and serves as a versatile receptor for vesicle-damaging pathogens.